D-erythro-Sphingosine-13C2,d2

CAS: 2692623-81-5 F: C1613C2H35D2NO2 W: 303.49

D-erythro-Sphingosine-13C2,d2 is a deuterated labeled D-erythro-Sphingosine. D-erythro-Sphingosine (Erythrosphingosine)

Contact QiTai

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity	D-erythro-Sphingosine-13C2,d2 is a deuterated labeled D-erythro-Sphingosine[1]. D-erythro-Sphingosine (Erythrosphingosine) is a very potent activator of p32-kinase with an EC50 of 8 μM, and inhibits protein kinase C (PKC). D-erythro-Sphingosine (Erythrosphingosine) is also a PP2A activator[2][3][4][5].
Invitro	氢、碳和其他元素的稳定重同位素已被纳入药物分子中，主要作为药物开发过程中定量的示踪剂。氘化引起了人们的关注，因为它可能影响药物的药代动力学和代谢谱[1]。p32-鞘氨醇激活的蛋白激酶对低浓度的 D-erythro-Sphingosine 有反应，在 2.5 μM 时观察到初始激活，在 10 -20 μM 时观察到峰值活性。该激酶显示出对 D-erythro-Sphingosine 相对于其他鞘氨醇立体异构体的适度特异性，并且对鞘氨醇的偏好优于对异氢鞘氨醇[2]。D-erythro-Sphingosine 在体外抑制蛋白激酶 C[3]。D-erythro-Sphingosine 已显示可抑制影响细胞调节和多种信号转导通路的蛋白激酶 C，并在多种哺乳动物细胞中表现出抗肿瘤启动子活性[4]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> D-erythro-Sphingosine-13C2,d2 相关抗体:
CAS	2692623-81-5
Formula	C1613C2H35D2NO2
Molar Mass	303.49
Transport	Room temperature in continental US; may vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Reference	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [2]. Cheng P, et al. Protein phosphatase 2A (PP2A) activation promotes axonal growth and recovery in the CNS. J Neurol Sci. 2015 Dec 15;359(1-2):48-56. [3]. Pushkareva MYu, et al. Regulation of sphingosine-activated protein kinases: selectivity of activation by sphingoid basesand inhibition by non-esterified fatty acids. Biochem J. 1993 Sep 15;294 ( Pt 3):699-703. [4]. Khan WA, et al. Protein kinase C and platelet inhibition by D-erythro-Sphingosine: comparison with N,N-dimethylsphingosine and commercial preparation. Biochem Biophys Res Commun. 1990 Oct 30;172(2):683-91. [5]. Pham VT, et al. A concise synthesis of a promising protein kinase C inhibitor: D-erythro-Sphingosine. Arch Pharm Res. 2007 Jan;30(1):22-7.